ACHV ACHV

Q: What is the current share price of ACHV?

As of 2026-08-05 17:25 PDT, ACHV trades at $6.66 on NASDAQ/NYSE. Its 52-week range is $2.44 to $6.66.

Q: What is the market capitalisation of ACHV?

ACHV has a market capitalisation of $354.54M on NASDAQ/NYSE.

Q: What is the P/E ratio of ACHV?

ACHV trades at a trailing price-to-earnings (P/E) ratio of -5.33. Its price-to-book (P/B) ratio is 16.48.

Q: Is ACHV a good stock to buy?

This page provides a data-driven analysis of ACHV, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Company Profile ↓

$6.66

+158.14% 1Y

Mkt Cap$354.54M

P/E-5.33

P/B16.48

52W High$6.66

52W Low$2.44

Book Value$0.40

EPS (TTM)$-1.25

Company Overview

ACHV (ACHV) is a publicly traded company listed on with a market capitalization of $354.54M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.

Growth & Price Performance

Stock Price Performance

1 Year:	+158.14%
6 Months:	+58.95%
3 Months:	+46.05%
1 Month:	+2.15%

Technical Snapshot Bullish

52-Week Range 100% of range

$2.44 $6.66

Trend Signals

Price vs 50-DMAAbove
Price vs 200-DMAAbove
RSI (14)62.85 · Neutral

Price Performance

1M+2.15%

3M+46.05%

6M+58.95%

1Y+158.14%

Auto-generated from price history and fundamentals; not investment advice.

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Period: Metric:

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

In a confirmed uptrend (50-DMA above 200-DMA).

CONS

No notable concerns flagged.

* The pros and cons are auto-generated from financial metrics.

Valuation

Stock P/E

-5.33

Industry PE

Forward P/E

PEG Ratio

Book Value

$0.40

Price to Book

16.48

P/S

EV/EBITDA

Dividend Yield

0.00%

Growth (CAGR)

Revenue 5Y

Profit 5Y

Revenue (YoY)

Earnings (YoY)

Profitability & Returns

ROCE

ROE

ROA

Profit Margin

Op Margin

Gross Margin

EPS (Latest Qtr)

$-0.19

EPS (TTM)

$-1.25

Balance Sheet & Liquidity

Debt/Equity

0.69

Quick Ratio

Current Ratio

4.39

Debt

$14.96M

Total Assets

$33.10M

Current Assets

$31.06M

Working Capital

$30.81M

Ownership

Promoter Holding

0.93%

Chg in Prom Hold

FII / Inst Holding

66.60%

Chg in FII Hold

Financial Snapshot

Enterprise Value

Total Revenue (TTM)

EBITDA

$-53.60M

Free Cash Flow

$-49.47M

Operating Cash Flow

$-49.47M

Shares Outstanding

53.23M

Gross Margin

Payout Ratio

Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric	Dec 2015	Mar 2016	Jun 2016	Sep 2016	Dec 2016	Mar 2017	Jun 2017	Sep 2017	Dec 2017	Mar 2018	Jun 2018	Sep 2018	Dec 2018	Mar 2019	Jun 2019	Sep 2019	Dec 2019	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Mar 2023	Jun 2023	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	12.89M	12.56M	14.69M	14.73M	10.46M
Operating Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-12.89M	-12.56M	-14.69M	-14.73M	-10.46M
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-12.58M	-12.47M	-14.20M	-14.35M	-9.84M
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	185.00K	191.00K	192.00K	251.00K	274.00K
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-12.83M	-12.72M	-14.44M	-14.66M	-10.17M
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-1.72M	-242.00K	-238.00K	-268.00K	-486.00K	-205.00K	-169.00K	-6.47M	-3.74M	-3.02M	-2.79M	-3.24M	-3.64M	-5.90M	-3.62M	-3.67M	-3.19M	-3.32M	-2.92M	-3.76M	-4.72M	-8.00M	-11.31M	-6.69M	-7.15M	-7.57M	-10.47M	-13.08M	-8.99M	-8.24M	-7.11M	-6.49M	-8.46M	-12.51M	-	-12.83M	-12.72M	-14.44M	-14.66M	-10.17M
Diluted EPS	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1.53	-0.71	-	-0.80	-1.08	-1.35	-0.50	-0.43	-0.34	-0.26	-0.25	-0.36	-	-0.37	-0.37	-0.28	-0.28	-0.19
R&D Expense	6.59M	65.00K	72.00K	69.00K	80.00K	61.00K	62.00K	825.00K	2.15M	1.20M	1.04M	1.54M	2.08M	4.05M	2.03M	1.82M	1.76M	1.54M	1.10M	1.89M	2.35M	5.64M	9.23M	4.59M	4.51M	4.39M	7.21M	9.87M	5.53M	4.58M	3.58M	2.80M	5.11M	7.61M	-	7.10M	6.71M	5.32M	-	-

Profit & Loss (Annual)

Figures in USD.

Metric	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Revenue	-	-	-	-	-	-	-	-	-	0	0	-	-	0	0	0	0
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	40.80M	27.25M	39.07M	54.88M
Operating Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-40.80M	-27.25M	-39.07M	-54.88M
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-40.33M	-26.73M	-37.42M	-53.60M
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	1.79M	2.85M	2.18M	819.00K
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-42.35M	-29.82M	-39.83M	-54.65M
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-5.48M	-12.58M	-14.67M	-21.10M	-31.85M	-26.24M	-828.00K	-1.23M	-10.58M	-12.69M	-16.39M	-14.73M	-33.15M	-42.35M	-29.82M	-39.83M	-54.65M
Diluted EPS	-	-	-	-	-	-	-	-	-	-	-	-5.42	-4.08	-4.00	-1.50	-1.24	-1.25
R&D Expense	20.21M	18.48M	21.55M	39.95M	55.32M	46.22M	25.11M	286.00K	3.10M	5.87M	9.67M	6.88M	23.97M	30.08M	15.81M	22.82M	-

Balance Sheet (Annual)

Figures in USD.

Metric	Dec 2008	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	May 2015	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Assets	-	-	89.92M	68.02M	82.02M	55.69M	56.29M	-	58.21M	3.81M	9.89M	19.08M	21.08M	40.30M	-	29.97M	19.37M	38.63M	41.79M
Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	27.33M	16.98M	36.47M	39.89M
Cash & Equivalents	7.62M	62.05M	23.53M	28.52M	18.07M	14.59M	27.90M	-	34.31M	15.00K	5.28M	9.52M	16.66M	35.85M	-	24.72M	15.50M	12.73M	20.91M
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Receivables	-	-	-	-	-	-	-	-	-	-	-	-	-	-	153.00K	105.00K	111.00K	0	-
Total Liabilities	-	-	45.79M	37.12M	15.81M	18.48M	22.23M	-	20.77M	3.20M	2.01M	3.28M	3.03M	3.01M	-	21.67M	20.82M	17.73M	20.27M
Current Liabilities	-	-	27.48M	30.79M	11.56M	14.93M	22.22M	-	20.66M	3.07M	2.01M	3.27M	2.87M	2.94M	-	21.60M	20.81M	6.68M	9.08M
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	14.92M	-	-	9.84M	11.19M
Total Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	16.20M	16.73M	9.96M	14.96M
Total Equity	10.71M	22.96M	44.12M	30.89M	66.21M	37.21M	34.06M	0	1.84M	610.00K	15.80M	15.80M	18.05M	37.29M	-	8.30M	-1.45M	20.90M	21.52M
Shares Outstanding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	17.90M	21.17M	34.69M	53.23M

Cash Flows (Annual)

Figures in USD.

Metric	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Operating Cash Flow	34.88M	-26.84M	-20.26M	-43.49M	-35.93M	-	-	-202.00K	-9.11M	-10.62M	-15.22M	-13.47M	-	-37.57M	-24.48M	-29.77M	-49.47M
Investing Cash Flow	2.23M	-59.13M	25.07M	-21.19M	32.43M	-	-	-	12.65M	-5.12M	5.04M	-17.00K	-	0	-21.00K	-21.58M	6.11M
Financing Cash Flow	17.35M	47.48M	219.00K	54.24M	10.00K	-	-	150.00K	2.00M	19.76M	17.32M	32.68M	-	19.32M	15.28M	48.53M	51.53M
Capital Expenditure	-15.00K	-68.00K	-79.00K	-291.00K	-253.00K	-82.00K	-371.00K	-46.00K	-	-46.00K	-53.00K	-17.00K	-	-	-21.00K	-	-4.00K
Free Cash Flow	34.86M	-26.91M	-20.34M	-43.78M	-36.18M	-	-	-248.00K	-	-10.67M	-15.27M	-13.49M	-	-37.57M	-24.50M	-29.77M	-49.47M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-	-	-	-	-18.25M	-9.22M	-2.82M	8.17M

Ratios (Annual)

Figures in %.

Metric	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Gross Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
ROE %	-23.9%	-28.5%	-47.5%	-31.9%	-85.6%	-77.0%	-45.0%	-202.3%	-67.0%	-80.3%	-90.8%	-39.5%	-	-510.1%	2,059.0%	-190.6%	-254.0%
ROCE %	-	-	-	-	-	-	-	-	-	-	-	-	-	-487.3%	1,889.7%	-122.3%	-167.8%

Shareholding Pattern

Insiders

0.93%

Institutions

66.60%

Public Float

67.23%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for ACHV

Google News Fri, 31 Jul 2026

ACHV Stock On Track To For Best Day In Over 7 Years — What’s Driving The Rally? - Stocktwits

<a href="https://news.google.com/rss/articles/CBMi0gFBVV95cUxPMjFJemgxWVdLcHBVWUJpZmZQNEtLQlZybEVPUDBDbEFRcjF3TEpGQUFtdUE4TDdZYkJvc1IyNDZhamdEREpuVEwwVlY0RHdfZDU0dTNFZHhJQ2JiZU5EY1FwRHY0NVdpOWlwZGh6a29TaDlQYWlvWDhleVJVWko0ZFRpaGNrSnFDdDlJTW…

Google News Fri, 31 Jul 2026

Six New Employees Receive Achieve Stock Awards Over Four Years - Stock Titan

<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxOby12b1Q2dnp1YnpZdldra2pqTi10S0ozWXJvdnBxdjhURjhxVnlwcTNmRzd3N0pybVN1OUpzZWl0aFEyU2xDUUxQTlk2bWJIQzNBV3ljbi1qX3dUQmo4OGI4VmNVb2RKWm5mZ0QyS3dtcDh1aTk1NjE0SUtsUDhETW5xaHFSeHhvRlB0X3…

Google News Sun, 02 Aug 2026

Achieve Life Sciences, Inc. (NASDAQ:ACHV) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat

<a href="https://news.google.com/rss/articles/CBMi2gFBVV95cUxNemlBQ3c0OEJ1Y19rOThFcTlkcTVPbGotYXVtVjZvTzM1cXRQV0pWNXVFWlFLb2FEdVFIckpWSE5ZUk13NkFYMVhoUU1NeWNOWGJibmRFU0lBN2l1R0FaVVo1cDM3UTRld0JIVHNFWFBLSlBrSkdCSDlvTGdsSDAwQnZlX0R6V19mNWJNdD…

Google News ue, 07 Jul 2026

Achieve Life Sciences: Despite CRL, A Success Is Achieve-Able (NASDAQ:ACHV) - Seeking Alpha

<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxQY21GVDM0SEprWV9yZExDOFdkODhGNGtLak8yYXAyTDRfeGl6VktpbEVCVVBsanI2VGxUYVpRUDVLdTBHU2Z2UFJ4Z1lmTEJBakFUMnlUSjFBTUplNUtEd28ycEctZTJ5UGtTeGczZ3RFSDVER2pmZFg0b2QyRVNtWTYxTDRQR3FJSWRzcz…

Google News hu, 25 Jun 2026

ACHV Forecast — Price Target — Prediction for 2027 - TradingView

<a href="https://news.google.com/rss/articles/CBMiekFVX3lxTE5paEJvZC0wUWwxUVNoQ3laaW11Y0dpVUNiZWd0dF9CdEt0TzR1TjdhNmIzV3M1Z0Z1OVJDQjVBMmR6Yk1mYmlwc19HTFlMNWRESGlBa2sxMHZia1ZkR3o4T0lzTjhjUlN3Q2NGOVc1czUya0M4Rm1JaS1B?oc=5" target="_blank">ACH…

Google News Sat, 01 Aug 2026

BlackRock, Inc. Expands Stake in Achieve Life Sciences (ACHV) wi - GuruFocus

<a href="https://news.google.com/rss/articles/CBMi1AFBVV95cUxPaVliVmNwUnpsWWg1ZXc4dmNpOEVnNkc4OXVpY3pEOGJPbDR6bEM1VURSTUhFMkF5ZndGazJ3ZWdEblYtU0hNOTl6TFlVZF9tM1lBV1EtakxHc0FCUEppdmJldmFlTTJSYkVHMHpTNTgta2RySW9xWnJTaHhKNTlLdVFselVsM3BUblhENT…

ACHV — Frequently Asked Questions

What is the current share price of ACHV?

As of 2026-08-05 17:25 PDT, ACHV trades at $6.66 on NASDAQ/NYSE. Its 52-week range is $2.44 to $6.66.

What is the market capitalisation of ACHV?

ACHV has a market capitalisation of $354.54M on NASDAQ/NYSE.

What is the P/E ratio of ACHV?

ACHV trades at a trailing price-to-earnings (P/E) ratio of -5.33. Its price-to-book (P/B) ratio is 16.48.

Is ACHV a good stock to buy?

This page provides a data-driven analysis of ACHV, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks

ACHV ACHV

Company Overview

Growth & Price Performance

Stock Price Performance

Price Chart

Technical Trend

Fundamental Growth Charts

PROS

CONS

Valuation

Growth (CAGR)

Profitability & Returns

Balance Sheet & Liquidity

Ownership

Financial Snapshot

Quarterly Results

Profit & Loss (Annual)

Balance Sheet (Annual)

Cash Flows (Annual)

Ratios (Annual)

Shareholding Pattern

Analyst View

Latest News

ACHV Stock On Track To For Best Day In Over 7 Years — What’s Driving The Rally? - Stocktwits

Six New Employees Receive Achieve Stock Awards Over Four Years - Stock Titan

Achieve Life Sciences, Inc. (NASDAQ:ACHV) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat

Achieve Life Sciences: Despite CRL, A Success Is Achieve-Able (NASDAQ:ACHV) - Seeking Alpha

ACHV Forecast — Price Target — Prediction for 2027 - TradingView

BlackRock, Inc. Expands Stake in Achieve Life Sciences (ACHV) wi - GuruFocus

ACHV — Frequently Asked Questions

What is the current share price of ACHV?

What is the market capitalisation of ACHV?

What is the P/E ratio of ACHV?

Is ACHV a good stock to buy?

Explore More